Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Drug & Device News
Citing Choice-of-Law Issues, Appeals Court Reverses Plaintiff Verdict in Accutane Case
An appeals court has reversed a $25 million verdict against Hoffmann-La Roche Inc. and Roche Laboratories in the case of a man who alleged he developed Crohn's disease after using the company's acne drug, Accutane. New Jersey's Appellate Division ruled Aug. 11 in McCarrell v. Hoffmann-La Roche that the filing of the suit was untimely because the trial court erred in applying New Jersey's statute of limitations to the case rather than the law of the plaintiff's home state, Alabama. This is the second reversal in this case; the first plaintiff verdict was rendered in 2007, but it was also thrown out on appeal.
David Buchanan of Seeger Weiss in New York is representing plaintiff McCarrell. Following the appellate decision, he said, “Mr. McCarrell has litigated against Roche for 12 years concerning the permanent and devastating injuries he developed from his use of Accutane, and has proven Roche's responsibility for those injuries in two separate trials. Today's result is very disappointing. On behalf of Mr. McCarrell, we will be seeking further review of today's decision by the New Jersey Supreme Court.”
'
FDA Warns Morning Sickness Drug Maker
When celebrity Kim Kardashian West touted a morning sickness medication to her followers on Instagram in August, the federal Food and Drug Administration (FDA) quickly responded with a warning letter to the drug's manufacturer, Duchesnay Inc.
Kardashian's post stated: “OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it's been studied and there was no increased risk to the baby. I'm so excited and happy with my results that I'm partnering with Duchesnay USA to raise awareness about treating morning sickness. If you have morning sickness, be safe and sure to ask your doctor about the pill with the pregnant woman on it and find out more www.diclegis.com; www.DiclegisImportantSafetyInfo.com.”
The FDA noted in its letter to the company that advertisements for FDA-approved drugs may not promote those products without also including warnings and information about contraindications for taking them. In the case of the Kardashian post, no risk information of any kind was provided. And although readers were told they could find further information at Duchesnay's Diclegis web sites, the FDA was not placated. It ordered the company either to cease publishing claims such as Kardashian's or cease distributing Diclegis through interstate commerce.
'
Citing Choice-of-Law Issues, Appeals Court Reverses Plaintiff Verdict in Accutane Case
An appeals court has reversed a $25 million verdict against Hoffmann-La
David Buchanan of
'
FDA Warns Morning Sickness Drug Maker
When celebrity Kim Kardashian West touted a morning sickness medication to her followers on Instagram in August, the federal Food and Drug Administration (FDA) quickly responded with a warning letter to the drug's manufacturer, Duchesnay Inc.
Kardashian's post stated: “OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it's been studied and there was no increased risk to the baby. I'm so excited and happy with my results that I'm partnering with Duchesnay USA to raise awareness about treating morning sickness. If you have morning sickness, be safe and sure to ask your doctor about the pill with the pregnant woman on it and find out more www.diclegis.com; www.DiclegisImportantSafetyInfo.com.”
The FDA noted in its letter to the company that advertisements for FDA-approved drugs may not promote those products without also including warnings and information about contraindications for taking them. In the case of the Kardashian post, no risk information of any kind was provided. And although readers were told they could find further information at Duchesnay's Diclegis web sites, the FDA was not placated. It ordered the company either to cease publishing claims such as Kardashian's or cease distributing Diclegis through interstate commerce.
'
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
How Secure Is the AI System Your Law Firm Is Using?
In a profession where confidentiality is paramount, failing to address AI security concerns could have disastrous consequences. It is vital that law firms and those in related industries ask the right questions about AI security to protect their clients and their reputation.
COVID-19 and Lease Negotiations: Early Termination Provisions
During the COVID-19 pandemic, some tenants were able to negotiate termination agreements with their landlords. But even though a landlord may agree to terminate a lease to regain control of a defaulting tenant's space without costly and lengthy litigation, typically a defaulting tenant that otherwise has no contractual right to terminate its lease will be in a much weaker bargaining position with respect to the conditions for termination.
Pleading Importation: ITC Decisions Highlight Need for Adequate Evidentiary Support
The International Trade Commission is empowered to block the importation into the United States of products that infringe U.S. intellectual property rights, In the past, the ITC generally instituted investigations without questioning the importation allegations in the complaint, however in several recent cases, the ITC declined to institute an investigation as to certain proposed respondents due to inadequate pleading of importation.
The Power of Your Inner Circle: Turning Friends and Social Contacts Into Business Allies
Practical strategies to explore doing business with friends and social contacts in a way that respects relationships and maximizes opportunities.
Authentic Communications Today Increase Success for Value-Driven Clients
As the relationship between in-house and outside counsel continues to evolve, lawyers must continue to foster a client-first mindset, offer business-focused solutions, and embrace technology that helps deliver work faster and more efficiently.